Literature DB >> 369783

The recovery period following exposure of bacteria to penicillins.

D A Wilson, G N Rolinson.   

Abstract

Experiments with Staphylococcus aureus and Streptococcus pyogenes have shown that when cells are exposed to bactericidal concentration of benzylpenicillin or ampicillin and the antibiotic then inactivated with beta-lactamase the count of the surviving viable cells (colony-forming units) remains essentially constant for a period of approximately 1.5--3 h before increasing at a normal rate. No such recovery period was observed, however, when Escherichia coli or Proteus mirabilis was exposed to a bactericidal concentration of ampicillin and the antibiotic then inactivated. Microscopic observation of individual surviving cells of S. aureus following exposure to benzylpenicillin showed that in some cases resumption of cell division was delayed as long as 4 h. However, other cells in the same population showed no recovery period and resumed division within 30 min of inactivation of the antibiotic. In the latter case, the recovery period which is observed in terms of viable count may represent the period of time required for individual surviving cells to divide and give rise to normal aggregates before these fragment to produce new colony-forming units.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 369783     DOI: 10.1159/000237817

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  16 in total

Review 1.  Continuous infusion of beta-lactam antibiotics.

Authors:  W A Craig; S C Ebert
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

2.  Pharmacodynamic effects of sub-MICs of benzylpenicillin against Streptococcus pyogenes in a newly developed in vitro kinetic model.

Authors:  E Löwdin; I Odenholt; S Bengtsson; O Cars
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

3.  Postantibiotic and bactericidal effect of imipenem against Pseudomonas aeruginosa.

Authors:  I Odenholt; B Isaksson; L Nilsson; O Cars
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-02       Impact factor: 3.267

4.  Flow cytometric assessment of the postantibiotic effect of methicillin on Staphylococcus aureus.

Authors:  M T Suller; D Lloyd
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

5.  Comparison of electronic and viability counting methods for determination of postantibiotic effect of oxacillin on Staphylococcus aureus.

Authors:  H L Nadler; W A Curby; P Forgacs; F Rosenberg
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

6.  Correlating Drug-Target Residence Time and Post-antibiotic Effect: Insight into Target Vulnerability.

Authors:  Shabnam Davoodi; Fereidoon Daryaee; Andrew Chang; Stephen G Walker; Peter J Tonge
Journal:  ACS Infect Dis       Date:  2020-02-14       Impact factor: 5.084

7.  Combined action of decreasing concentrations of azlocillin and sisomicin on Pseudomonas aeruginosa as assessed in a dynamic in vitro model.

Authors:  I Haller
Journal:  Infection       Date:  1982       Impact factor: 3.553

8.  Treatment of gram-negative bacillary septicemia with cefoperazone.

Authors:  H Lagast; F Meunier-Carpentier; J Klastersky
Journal:  Eur J Clin Microbiol       Date:  1983-12       Impact factor: 3.267

9.  Postantibiotic sub-MIC effects of vancomycin, roxithromycin, sparfloxacin, and amikacin.

Authors:  I Odenholt-Tornqvist; E Löwdin; O Cars
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

Review 10.  Pharmacokinetic contributions to postantibiotic effects. Focus on aminoglycosides.

Authors:  G G Zhanel; W A Craig
Journal:  Clin Pharmacokinet       Date:  1994-11       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.